Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
application to N-terminal pyroglutamyl unblocking prior to Edman sequential degradation in peptide and protein sequencing
analysis
-
pyroglutamyl aminopeptidase is an auxiliary enzyme in a spectrometric assay for glutaminyl cyclase activity. It is a fast, continuous, and reliable determination of glutaminyl cyclase activity, even in the presence of ammonium ions, during the course of protein purification and enzymatic analysis
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
analysis
-
the enzyme may be a useful single-test adjunct for distinguishing Staphylococcus aureus from Staphylococcus delphini and other members of the Staphylococcus intermedius group
-
medicine
-
the natural oligosaccharide gum from Hakea gibbosa is an effective non-competitive inhibitor. The natural gum may be a promising additive not only for its sustained-release and mucoadhesive properties, but also for its ability to slow the enzymatic degradation of therapeutic polypeptides incorporated in dosage forms
medicine
-
diabetes mellitus affects the levels of hippocampal and hypothalamic PAP-I activities, which may change the metabolic control of its susceptible physiological peptide substrates in the brain
medicine
-
overexpression of active PPI in Leishmania major impairs differentiation from the procyclic promastigote to the infective metacyclic promastigote. PPI does not protect against the natural antimicrobial peptide gomesin
medicine
-
profiles of macrophage and renal PAP activities may be considered into the elaboration of new potential strategies for preventing nephrotoxicity during cyclosporin treatment
medicine
-
examination of Peptoclostridium difficile isolates from children with hematological malignancies, diarrhoea and from healthy neonates. All strains from children with hematological malignancies react with the substrate for L-pyrrolidone arylamidase
medicine
-
analysis of enzymic activity in serum of controls and patients diagnosed with pancreatitis, hepatitis, and liver cirrhosis. Pyroglutamyl-aminopeptidase activity decreases selectively in liver cirrhosis compared with all the rest of groups
medicine
-
healthy post-menopausal women show higher values of pyroglutamyl-peptidase I activity than pre-menopausal women. No differences are found in serum pyroglutamyl-peptidase activity between pre- and post-menopausal women with breast cancer. Only post-menopausal women with breast cancer show lower values of pyroglutamyl-peptidase activity than control women
additional information
C-terminal alpha-helix in the D1 state plays an important role in retaining the D1 state under the stable conditions and in correctly folding into the native structure of PCP-0SH
additional information
-
C-terminal alpha-helix in the D1 state plays an important role in retaining the D1 state under the stable conditions and in correctly folding into the native structure of PCP-0SH